Genetic vaccine for melanoma hailed as world breakthrough

Abstract

High-efficiency gene transfer systems have been used to produce a vaccine against melanoma. The vaccine is likely to provide strong competition to the antigenic vaccines now in clinical trials for this indication. Details of the first patient to be treated with the genetic vaccine were presented at the International Conference on Melanoma [ Brisbane, Australia; April 1994 ]. The positive results have aroused international interest, and larger clinical trials are due to begin.